Suchergebnisse - "Udry, Sebastián"

PubPharm (27)

21

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?

enthalten in: Immunologic research | 2018

von Latino, J. | Udry, S. | Wingeyer, S. | +3

22

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

enthalten in: Journal of assisted reproduction and genetics | 2018

von Aranda, F. | Udry, S. | Perés Wingeyer, S. | +6

23

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome : A Multicentre Study

enthalten in: Thrombosis and haemostasis | 2018

von Ruffatti, A. | Tonello, M. | Hoxha, A. | +26

24

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

enthalten in: Journal of assisted reproduction and genetics | 2018

von Aranda, F. | Udry, S. | Perés Wingeyer, S. | +6

25

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

enthalten in: Journal of assisted reproduction and genetics | 2018

von Aranda, F. | Udry, S. | Perés Wingeyer, S. | +6

26

Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

enthalten in: Journal of assisted reproduction and genetics | 2018

von Aranda, F. | Udry, S. | Perés Wingeyer, S. | +6

27

Annexins and recurrent pregnancy loss

enthalten in: Medicina | 2013

von Udry, S. | Aranda, F. | Latino, O. | +1